Dose Reduction Strategy for Amitiza-Induced Diarrhea
If Amitiza is causing excessive diarrhea, you should first reduce the dose rather than scheduling it intermittently a few days per week, as dose-dependent side effects (including diarrhea) can be mitigated by lowering the daily dose while maintaining consistent daily administration.
Algorithmic Approach to Managing Amitiza-Related Diarrhea
Step 1: Assess Severity and Discontinue if Severe
- If severe diarrhea occurs: Discontinue Amitiza immediately and contact healthcare provider 1
- The FDA label explicitly instructs to "avoid use of Amitiza in patients with severe diarrhea" and to "discontinue Amitiza and contact their healthcare provider if severe diarrhea occurs" 1
Step 2: Dose Reduction Strategy (For Mild-Moderate Diarrhea)
For Chronic Idiopathic Constipation (CIC):
- Standard dose: 24 mcg twice daily
- Reduce to 16 mcg twice daily (for moderate hepatic impairment dosing) 1
- Further reduce to 8 mcg twice daily if needed (severe hepatic impairment dosing) 1
- In long-term studies, 17% of patients successfully reduced their dose in response to symptom severity, resulting in an average exposure of approximately 40.8 mcg per day (1.7 capsules) rather than the full 48 mcg 2
For IBS-C:
- Standard dose is already lower: 8 mcg twice daily 3
- Can reduce to 8 mcg once daily if diarrhea occurs 1
Step 3: Optimize Administration Timing
- Always take with food and water - this reduces both nausea and diarrhea risk 3
- The risk of diarrhea is dose-dependent and appears lower when taken with meals 3
Why Not Intermittent Scheduling?
The evidence does not support intermittent (few days per week) dosing for several reasons:
No clinical trial data: All efficacy studies used consistent daily dosing (twice daily) 3. There are no studies evaluating intermittent weekly scheduling.
Mechanism of action: Lubiprostone works by activating chloride channels to increase intestinal fluid secretion 3. This mechanism requires consistent dosing to maintain therapeutic effect.
Withdrawal effects: A 7-week randomized withdrawal study showed that when patients stopped Amitiza, their spontaneous bowel movement frequency returned toward baseline within 1 week 1. This suggests intermittent dosing would lead to fluctuating constipation symptoms.
Dose-dependent side effects: The evidence clearly shows that diarrhea risk is dose-dependent 3, with a 5.3-fold increased risk compared to placebo (RR 5.30,95% CI 1.53-18.44) 3. This means lowering the daily dose is the appropriate strategy, not skipping days.
Common Pitfalls to Avoid
- Don't continue full dose with intermittent scheduling: This exposes patients to the same high dose that caused diarrhea, just less frequently
- Don't forget food administration: Taking without food increases GI side effects
- Don't ignore severe diarrhea: This can lead to dehydration, syncope, and hypotension 1
- Monitor for syncope/hypotension: Diarrhea increases risk of these serious adverse events, which have resulted in hospitalization 1
Alternative Consideration
If dose reduction fails to control diarrhea, consider switching to an alternative secretagogue rather than continuing intermittent Amitiza:
- Lubiprostone is noted to be "less likely to cause diarrhea than others" among secretagogues 4
- However, if a patient cannot tolerate even reduced-dose lubiprostone, other laxative classes or constipation treatments should be considered
The evidence supports dose reduction with consistent daily administration, not intermittent weekly scheduling, as the appropriate management strategy for Amitiza-induced diarrhea.